Yubo International Biotech Limited is a U.S. holding company (New York corporation) that operates in China through contractual arrangements with its VIE, Yubo International Biotech (Beijing) Limited. The company conducts biotechnology and biomedical operations in China via subsidiaries including Yubo Phoenix, Yubo Jingzhi, and Yubo Shenzhen. Day-to-day business operations are conducted by Yubo Beijing in China. The holding company structure uses VIE arrangements due to PRC restrictions on direct foreign investment in certain industries.
Q2 FY2026 — expected 2026-07-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001640334-26-000598 | EDGAR | 62K words |
| 2025-03-31 | 2024-12-31 | 0001640334-25-000547 | EDGAR | — |
| 2024-04-12 | 2023-12-31 | 0001640334-24-000618 | EDGAR | — |
| 2023-04-14 | 2022-12-31 | 0001640334-23-000632 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001640334-22-000807 | EDGAR | — |
| 2020-06-25 | 2020-02-29 | 0001193805-20-000741 | EDGAR | — |
| 2019-06-12 | 2019-02-28 | 0001193805-19-000571 | EDGAR | — |
| 2018-06-13 | 2018-02-28 | 0001193805-18-000835 | EDGAR | — |
| 2017-06-14 | 2017-02-28 | 0001193805-17-001102 | EDGAR | — |
| 2016-06-10 | 2016-02-29 | 0001193805-16-003444 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001640334-25-002083 | EDGAR | 27K words |
| 2025-08-13 | 2025-06-30 | 0001640334-25-001439 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001640334-25-000837 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001640334-24-001693 | EDGAR | — |
| 2024-08-19 | 2024-06-30 | 0001640334-24-001300 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001640334-24-000849 | EDGAR | — |
| 2023-11-20 | 2023-09-30 | 0001640334-23-002200 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001640334-23-001530 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001640334-23-000848 | EDGAR | — |
| 2022-11-16 | 2022-09-30 | 0001640334-22-002469 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001640334-22-001779 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001640334-22-001053 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-01-16 | 0001640334-26-000105 | EDGAR | 1K words |
| 2025-07-25 | 0001640334-25-001318 | EDGAR | — |
| 2025-01-06 | 0001640334-25-000025 | EDGAR | — |
| 2022-11-10 | 0001640334-22-002376 | EDGAR | — |
| 2022-09-09 | 0001640334-22-001940 | EDGAR | — |
| 2021-04-13 | 0001640334-21-000872 | EDGAR | — |
| 2021-02-05 | 0001640334-21-000289 | EDGAR | — |
| 2021-01-14 | 0001640334-21-000097 | EDGAR | — |
| 2020-12-04 | 0001640334-20-003007 | EDGAR | — |
| 2020-10-16 | 0001640334-20-002574 | EDGAR | — |
111 total filings indexed. 79 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000895464 |
| Ticker | YBGJ |
| Exchange | OTC |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | NY |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report